2008 National Health Policy Conference: House, Senate staffers see little change in healthcare this year Feb. 6, 2008 By Mark McCarty
Amgen Unloads 13 Molecules in $1B-plus Deal with Takeda Feb. 5, 2008 By Donna Young Amgen Inc. is selling the Japanese rights to 13 molecules, including the FDA-approved colorectal drug Vectibix (panitumumab), to Takeda Pharmaceutical Co. Ltd. in a deal potentially worth more than $1 billion. (BioWorld Today)Read More
RSS